After a short-lived approval to generate and offer copycat variations of Eli Lilly’s excessive weight medications ran out recently, the drugmaker is escalating its initiatives to avoid compounders from additional sales.
发布者:BY KRISTOFFER GRONBAEK,转转请注明出处:https://robotalks.cn/lilly-threatens-copycat-drugmakers-after-zepbound-shortage/